Back to Search
Start Over
Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship.
- Source :
-
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2020 Aug; Vol. 26 (8), pp. 865-869. Date of Electronic Publication: 2020 May 13. - Publication Year :
- 2020
-
Abstract
- We investigated the clinical course of individuals with 2019 novel coronavirus disease (COVID-19) who were transferred from the Diamond Princess cruise ship to 12 local hospitals. The conditions and clinical courses of patients with pneumonia were compared with those of patients without pneumonia. Among 70 patients (median age: 67 years) analyzed, the major symptoms were fever (64.3%), cough (54.3%), and general fatigue (24.3%). Forty-three patients (61.4%) had pneumonia. Higher body temperature, heart rate, and respiratory rate as well as higher of lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and C-reactive protein (CRP) levels and lower serum albumin level and lymphocyte count were associated with the presence of pneumonia. Ground-glass opacity was found in 97.7% of the patients with pneumonia. Patients were administered neuraminidase inhibitors (20%), lopinavir/ritonavir (32.9%), and ciclesonide inhalation (11.4%). Mechanical ventilation and veno-venous extracorporeal membrane oxygenation was performed on 14 (20%) and 2 (2.9%) patients, respectively; two patients died. The median duration of intubation was 12 days. The patients with COVID-19 transferred to local hospitals during the outbreak had severe conditions and needed close monitoring. The severity of COVID-19 depends on the presence of pneumonia. High serum LDH, AST and CRP levels and low serum albumin level and lymphocyte count were found to be predictors of pneumonia. It was challenging for local hospitals to admit and treat these patients during the outbreak of COVID-19. Assessment of severity was crucial to manage a large number of patients.<br />Competing Interests: Declaration of Competing Interest The authors have no conflict of interest to declare.<br /> (Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Subjects :
- Aged
COVID-19
Coronavirus Infections complications
Diabetes Complications complications
Female
Humans
Hypertension complications
Japan
Male
Middle Aged
Pandemics
Patient Acuity
Pneumonia, Viral complications
Pneumonia, Viral virology
Prognosis
SARS-CoV-2
Ships
Betacoronavirus
Coronavirus Infections physiopathology
Coronavirus Infections therapy
Disease Outbreaks
Pneumonia, Viral physiopathology
Pneumonia, Viral therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1437-7780
- Volume :
- 26
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 32405245
- Full Text :
- https://doi.org/10.1016/j.jiac.2020.05.005